BMP-2 treatment activates the Hippo kinase cascade, which includes mammalian Ste20-like kinase 1 (MST1), MOB kinase activator 1 (MOB1), and YAP (inactivation), and this action is tumor suppressive. The gene discussed is BMP2; the disease is neoplasm.